Frontlight ResearchEarly access
Trial site
Hirosaki University Hospital
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Atrial fibrillation2 trials
- Gastric and oesophageal cancer1 trial
- High blood pressure1 trial
- IgA nephropathy1 trial
- Phase
- Phase 35 trials
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Amgen2 trials
- Biogen1 trial
- Boston Scientific Corporation1 trial
- Daiichi Sankyo1 trial
- Janssen Research & Development, LLC1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- IgA nephropathy1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026